This site is intended for healthcare professionals
News

Insmed’s Arikayce receives marketing authorization for treatment of mycobacterial lung infections

Read time: 1 mins
Last updated:29th Oct 2020
Published:29th Oct 2020
Condition: Mycobacterial Lung Disease
Type: drug
Register free for full access to medthority.com